Axes 1–2 · Brand Index
Conditional score and coverage
Opacity share 0.0%. Brand results are not ordered when coverage bounds overlap. A brand-level sensitivity interval is undefined because the release preserves formulation-level intervals.
brand · release 2026-09-20
Solgar
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Formulations31
Conditional mean GIS84.72
Coverage29.0%
Axes 3–4
Measurement status and document panel
Not a measurement product, so this axis does not apply.
No brand review panel is published in this release.
Price column
Brand price aggregation
undefined: prices are retained at label-version level and are not averaged across formulations.
Brand profile
What this brand's labels look like as a set
- Named strains
- 5 distinct designations printed across the 8 published products of this brand, compared without regard to letter case: BB-12, GG, LP299, La-5, Lp-299v
- Potency basis
- Potency is stated at manufacture. 4 · Potency is stated through expiry. 9 · The potency basis is not stated. 6 · counted across 19 organism rows on its labels, not across products
- Printed CFU across its labels
- 250,000,000 – 30,000,000,000; median 1,250,000,000. Measured on the 9 of 19 organism rows that print a per-organism figure; labels stating only a blend total are not in this range.
- Forms
- Capsule: 6 · Other (e.g. tea bag): 2 · counted across the 8 of 8 products whose label states a form
- Observed prices
- 0 of 8 published products
- Printed claims per label
- 2 on average across the 8 of 8 products whose label carries a parsed claim block. A printed claim is not evidence and enters no axis.
- Observed reformulations
- 4 label change(s) with a printed CFU or potency-basis change, counted only between two snapshots whose ingredient rows were both parsed
Products
Published product pages of this brand
| Product | Gut Index Score |
|---|---|
| Solgar Advanced Acidophilus Plus | 100.00 |
| Solgar Advanced Multi-Billion Dophilus | 84.25 |
| Solgar Advanced Pro-Bio Beads | 61.75 |
| Solgar Pro-Bio Beads | 66.25 |
| Solgar Probi 20 | 100.00 |
| Solgar Probi 20 Billion | 100.00 |
| Solgar Probi 30 | 77.19 |
| Solgar Probi 30 Billion | 73.00 |
Organisms
What this brand actually puts on its labels
Across its published products, 13 distinct organisms or ingredients are printed. The most frequent, with the number of published products carrying each:
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Potency basis census · Supplier code network · Label designation changes
Tools: DSLD product check
Citation
Cite this page
Ivitskiy, I. (2026). Solgar. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/b/solgar/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Solgar has 20 eligible SKUs and 31 formulation groups among labels in the NIH DSLD snapshot (Sep 2026).
20 / 31 formulation groups · NIH DSLD snapshot Sep 2026 · brand.skus · checked 2026-09-20T00:00:00Z · snapshot b7633f73243713 of 31 Solgar formulation groups have at least one printed strain designation (41.9%) in the NIH DSLD snapshot Sep 2026.
13 / 31 formulation groups · NIH DSLD snapshot Sep 2026 · brand.naming · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 31 Solgar formulation groups were scored using the available matching evidence (0.0%) in the NIH DSLD snapshot Sep 2026.
0 / 31 formulation groups · NIH DSLD snapshot Sep 2026 · brand.opacity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437Solgar: conditional Brand Index 84.72 from 9 of 31 formulation groups with numeric Gut Index Scores (29.0%); unscored groups remain outside the mean. Window: NIH DSLD snapshot Sep 2026.
9 / 31 formulation groups · NIH DSLD snapshot Sep 2026 · brand.index · checked 2026-09-20T00:00:00Z · snapshot b7633f732437